Morisada, Naoya
Ioroi, Tomoaki
Taniguchi-Ikeda, Mariko
Juan Ye, Ming
Okamoto, Nobuhiko
Yamamoto, Toshiyuki http://orcid.org/0000-0002-9484-3505
Iijima, Kazumoto
Article History
Received: 31 May 2016
Revised: 21 July 2016
Accepted: 21 July 2016
First Online: 15 September 2016
Competing interests
: KI has received grants from Daiichi Sankyo, Japan Blood Product Organization, Miyarisan Pharmaceutical, AbbVie LLC, CSL Behring, JCR Pharmaceuticals, Teijin Pharma, Novo Nordisk Pharma, AIR WATER MEDICAL, Astellas Pharma, Takeda Pharmaceutical Company and Taisho Toyama Pharmaceutical, as well as lecture fees from Meiji Seika Pharma, Novartis Pharma K.K., Zenyaku Kogyo, Chugai Pharmaceutical, Daiichi Sankyo, Springer Japan, Asahi Kasei Pharma, Boehringer Ingelheim, Medical Review, NIKKEI RADIO BROADCASTING CORPORATION, Japan Blood Product Organization and CSL Behring, manuscript fees from Chugai Pharmaceutical and consulting fees from Zenyaku Kogyo, Chugai Pharmaceutical, Astellas Pharma, Takeda Pharmaceutical Company and Ono Pharmaceutical.